Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

NCT00803309 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
99
Enrollment
NETWORK
Sponsor class

Stopped At the end of the planned recruitment period the expected number of subjects could not be included in the trial.

Conditions

Interventions

Sponsor

HepNet Study House, German Liverfoundation

Collaborators